中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2015年
14期
13-13,15
,共2页
中药药剂学%中药%细胞级粉碎%应用研究
中藥藥劑學%中藥%細胞級粉碎%應用研究
중약약제학%중약%세포급분쇄%응용연구
Chinese drugs pharmaceutics%Traditional Chinese Medicine%Cellular level pulverizing%Application research
目的:分析与探讨中药细胞级粉碎在中药药剂学中的应用。方法:随机选取西洋参、川贝母、天麻、云芝及三七各1000 g,并将这些药材平均分为对照组与试验组,对照组实施常规粉碎技术,试验组实施细胞级粉碎技术,对两组中药粉碎后颗粒细度变化进行观察与对比。结果:对照组粉碎后的粒度变化程度明显比试验组低,差异具有统计学意义(P<0.05)。结论:在中药药剂学中应用中药细胞级粉碎技术,能够有效溶出中药有效成分,人体更易吸收,能够显著提高中药有效成分利用率。
目的:分析與探討中藥細胞級粉碎在中藥藥劑學中的應用。方法:隨機選取西洋參、川貝母、天痳、雲芝及三七各1000 g,併將這些藥材平均分為對照組與試驗組,對照組實施常規粉碎技術,試驗組實施細胞級粉碎技術,對兩組中藥粉碎後顆粒細度變化進行觀察與對比。結果:對照組粉碎後的粒度變化程度明顯比試驗組低,差異具有統計學意義(P<0.05)。結論:在中藥藥劑學中應用中藥細胞級粉碎技術,能夠有效溶齣中藥有效成分,人體更易吸收,能夠顯著提高中藥有效成分利用率。
목적:분석여탐토중약세포급분쇄재중약약제학중적응용。방법:수궤선취서양삼、천패모、천마、운지급삼칠각1000 g,병장저사약재평균분위대조조여시험조,대조조실시상규분쇄기술,시험조실시세포급분쇄기술,대량조중약분쇄후과립세도변화진행관찰여대비。결과:대조조분쇄후적립도변화정도명현비시험조저,차이구유통계학의의(P<0.05)。결론:재중약약제학중응용중약세포급분쇄기술,능구유효용출중약유효성분,인체경역흡수,능구현저제고중약유효성분이용솔。
Objective:To analyze and explore the application of cellular level pulverizing in Chinese drugs pharmaceutics for traditional Chinese medicine.Methods:1 000 g american ginseng,unibract fritillary bulb,gastrodia elata,rainbow conk and notoginseng were randomly selected.These herbs were average divided into the control group and the experimental group.The control group was given routine pulverizing technology,the experimental group was given cellular level pulverizing technology.The changes of particle fineness were observed and compared between traditional Chinese medicines of two groups after pulverizing. Results:The particle fineness change degree of the control group after pulverizing was lower than that of the experimental group, the difference was statistically significant(P<0.05).Conclusion:Application of traditional Chinese medicine cellular level pulverizing technology in Chinese drugs pharmaceutics can effectively dissolved the effective ingredients of traditional Chinese medicine,and the body is more easily absorbed.It can significantly improve the utilization rate of effective components of traditional Chinese medicine.